Amy E. Monaghan
Impact in
-
- Neuropeptides and Animal Physiology
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 5
-
- Adenosine and Purinergic Signaling 4
- Co-authors
- Tom I. Bonner (1 shared paper)Chidochangu P. Mpamhanga (1 shared paper)Joanna L Sharman (1 shared paper)Adam J Pawson (1 shared paper)Anthony J. Harmar (1 shared paper)Helen E. Benson (1 shared paper)Wen Chiy Liew (1 shared paper)Anthony P. Davenport (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)eLife (1 paper)Pharmacological Reviews (1 paper)Assay and Drug Development Technologies (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Amy E. Monaghan
23 papers receiving 487 citations
Peers
Comparison fields: 5 of 65
- Cellular and Molecular Neuroscience 104
- Physiology 22
- Biochemistry 32
- Pharmacology 70
- Molecular Biology 296
Countries citing papers authored by Amy E. Monaghan
This map shows the geographic impact of Amy E. Monaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Monaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Monaghan more than expected).
Fields of papers citing papers by Amy E. Monaghan
This network shows the impact of papers produced by Amy E. Monaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Monaghan. The network helps show where Amy E. Monaghan may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Monaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 269 | |
| 2 | 2022 | 41 | |
| 3 | 2019 | 25 | |
| 4 | 2021 | 24 | |
| 5 | 2020 | 19 | |
| 6 | 2019 | 16 | |
| 7 | 2020 | 16 | |
| 8 | 2021 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2019 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2019 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2023 | 2 | |
| 20 | Course Development in Distance Education: Whose is the Content? | 2008 | 1 |
About Amy E. Monaghan
Amy E. Monaghan is a scholar working on Pharmacology, Physiology, Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry, having authored 26 papers that have together received 490 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Chemokine receptors and signaling (4 papers), Computational Drug Discovery Methods (4 papers), Immune cells in cancer (4 papers), Adenosine and Purinergic Signaling (4 papers), Cancer-related gene regulation (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (104 citations), Physiology (22 citations), Biochemistry (32 citations), Pharmacology (70 citations) and Molecular Biology (296 citations). Amy E. Monaghan has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Tom I. Bonner, Chidochangu P. Mpamhanga, Joanna L Sharman, Adam J Pawson, Anthony J. Harmar, Helen E. Benson, Wen Chiy Liew, Anthony P. Davenport, Stephen Alexander and Richard R. Neubig. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, eLife, Pharmacological Reviews and Assay and Drug Development Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.